CRA
ICON plc
Summary
At ICON Strategic Solutions, you will work in a sponsor-dedicated model, supported by ICON's global expertise. As a CRA II at ICON, you will perform site qualification, initiation, monitoring and closeout activities as assigned.
Job description
What You Will Do
You will contribute to clinical trial monitoring activities, taking responsibility for your deliverables and working collaboratively.
Key responsibilities include
- Perform site qualification, initiation, monitoring and closeout activities as assigned.
- Verify protocol, GCP and regulatory compliance and participant protection.
- Review source data, essential documents and site processes for accuracy and completeness.
- Identify and follow up findings, risks and corrective actions.
- Maintain clear communication with investigators, site staff and study teams.
Working conditions
- Willingness to travel as required (approximately 60%).
Requirements
- Relevant life sciences, healthcare or clinical research qualification, or equivalent relevant clinical research experience
- Minimum of 2 years of experience as a Clinical Research Associate
- In-depth knowledge of clinical trial processes, regulations, and ICH Good Clinical Practice (GCP) guidelines
- Knowledge of ICH Good Clinical Practice (GCP), clinical trial conduct and site monitoring requirements
- Practical experience with site monitoring or site management appropriate to the level of role
- Experience performing site qualification, initiation, monitoring and closeout activities
- Experience verifying protocol, GCP and regulatory compliance and participant protection
- Willingness to travel approximately 60%
- Legal right to work in the country where the role is based
Benefits
- Competitive base salary
- Performance related incentives
- Medical, Dental & Vision
- Retirement and pension plans
- Life assurance and disability coverage
- Employee assistance programmes
- Wellbeing resources
- Learning and development opportunities
Company overview
ICON plc is a global leader in clinical research and healthcare intelligence, founded in Dublin, Ireland in 1990. As one of the world's largest contract research organizations (CROs), ICON provides comprehensive outsourced development services to pharmaceutical, biotechnology, and medical device companies worldwide. The company operates in 55 countries with approximately 41,900 employees, offering end-to-end solutions that span the entire product development lifecycle. ICON's service portfolio includes clinical research services, adaptive trials, biosimilars, commercialization and outcomes consulting, medical imaging, laboratory services, and strategic support for traditional and digital health technologies. The company specializes in therapeutic areas such as oncology, cardiovascular diseases, central nervous system disorders, rare diseases, and women's health. With its 2021 acquisition of PRA Health Sciences, ICON significantly expanded its capabilities and market position, becoming a dominant force in the global CRO industry. The company is publicly traded on NASDAQ under the ticker ICLR and reported $8.28 billion in revenue for 2024.